Abstract

The number of mature oocytes is a key factor in the success of Assisted Reproductive Techniques (ART). Exogenous gonadotropins are administered during ovarian stimulation in order to maximize the number of oocytes available for fertilization. During stimulation, monitoring is mandatory to evaluate individual response, to avoid treatment complications and assist in the determination of the optimal day for final oocyte maturation and oocyte retrieval. Routine monitoring during stimulation includes transvaginal ultrasound examinations and measurement of serum estradiol (E2). Due to multifollicular growth of follicles of varying size, serum E2 levels are commonly supraphysiological and often variable, rendering E2-measurement during ovarian stimulation unreliable as a determinant of oocyte maturity. In contrast to serum E2, serum Inhibin A levels increase once a minimum follicle size of 12–15 mm is achieved. Due to this fact, serum Inhibin A levels could present in combination with ultrasound monitoring a more reliable parameter to determine the optimal follicle size for final oocyte maturation, as only follicles with a size of 12 mm and beyond will contribute to the serum Inhibin A level. This prospective observational, cross-sectional study demonstrates, that on the day of final oocyte maturation serum Inhibin A is strongly correlated to the number of follicles ≥15 mm (0.72) and to the number of retrieved and mature oocytes (ρ 0.82/0.77, respectively), whereas serum E2 is moderately correlated to the parameters mentioned above (ρ 0.64/0.69/0.69, respectively). With an area under the curve (AUC) of 0.91 for Inhibin A, compared to an AUC of 0.84 for E2, Inhibin A can be regarded as a better predictor for the optimal timing of trigger medication with a threshold number of ≥10 mature oocytes. It can be concluded from this data that serum Inhibin A in combination with transvaginal ultrasound monitoring may be a more powerful tool in the decision making process on trigger timing as compared to E2.

Highlights

  • The number of retrieved oocytes is critical to the success of IVF treatment

  • Results of blood samples and parameters from the ovarian stimulation treatment for IVF/ICSI were available from a total of 145 patients at the start of ovarian stimulation and from 136 patients on the day of final oocyte maturation

  • A statistically highly significant correlation was found between antral follicle count (AFC) and Inhibin B (p

Read more

Summary

Introduction

The number of retrieved oocytes is critical to the success of IVF treatment. As a result, the aim of ovarian stimulation for IVF is to maximize the number of oocytes available for fertilization [1, 2]. In order to achieve this goal, ovarian stimulation prior to IVF requires the administration of exogenous gonadotropins to support multi-follicular growth until the day of final oocyte maturation [3]. Despite the assessment of these parameters as an indicator for the expected treatment response prior to cycle initiation, close monitoring of individual response to ovarian stimulation is mandatory to avoid treatment complications, facilitate individualization of treatment and assist in the determination of the optimal day for final oocyte maturation and oocyte retrieval. With TVUS, ovarian response to gonadotropin administration is monitored by recording the size and number of developing antral follicles and serum E2 levels that reflect the collective hormonal capacity of the follicles

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.